{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T18:08:51Z","timestamp":1769364531517,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier","isbn-type":[{"value":"9780128228357","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/b978-0-12-822835-7.00002-0","type":"book-chapter","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T11:42:02Z","timestamp":1661514122000},"page":"269-283","source":"Crossref","is-referenced-by-count":1,"title":["Tumour treating fields"],"prefix":"10.1016","author":[{"given":"Maria","family":"Diaz","sequence":"first","affiliation":[]},{"given":"Robert J.","family":"Young","sequence":"additional","affiliation":[]},{"given":"Pedro C.","family":"Miranda","sequence":"additional","affiliation":[]},{"given":"Cornelia","family":"Wenger","sequence":"additional","affiliation":[]},{"given":"Joshua","family":"Lantos","sequence":"additional","affiliation":[]},{"given":"Eric T.","family":"Wong","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-822835-7.00002-0_bib1","series-title":"ASCO 2012 Education Book","first-page":"126","article-title":"Noninvasive application of alternating electric fields in glioblastoma: a fourth cancer treatment modality","author":"Gutin","year":"2012"},{"issue":"3","key":"10.1016\/B978-0-12-822835-7.00002-0_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01868659","article-title":"Electric field-induced cell-to-cell fusion","volume":"67","author":"Zimmermann","year":"1982","journal-title":"J\u00a0Membr Biol"},{"key":"10.1016\/B978-0-12-822835-7.00002-0_bib3","series-title":"Dielectrophoresis","author":"Pohl","year":"1978"},{"issue":"9","key":"10.1016\/B978-0-12-822835-7.00002-0_bib4","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1158\/0008-5472.CAN-04-0083","article-title":"Disruption of cancer cell replication by alternating electric fields","volume":"64","author":"Kirson","year":"2004","journal-title":"Canc Res"},{"issue":"suppl 6","key":"10.1016\/B978-0-12-822835-7.00002-0_bib5","first-page":"vi9","article-title":"Mitosis interference of cancer cells by NovoTTF-100A causes decreased cellular viability","volume":"14","author":"Lee","year":"2012","journal-title":"Neuro Oncol"},{"issue":"suppl 3","key":"10.1016\/B978-0-12-822835-7.00002-0_bib6","first-page":"iii66","article-title":"Disruption of cell division within anaphase by tumor treating fields (TTFields) leads to immunogenic cell death","volume":"15","author":"Lee","year":"2013","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/B978-0-12-822835-7.00002-0_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nri2216","article-title":"Immunological aspects of cancer chemotherapy","volume":"8","author":"Zitvogel","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/B978-0-12-822835-7.00002-0_bib8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/B978-0-12-822835-7.00002-0_bib9","doi-asserted-by":"crossref","first-page":"10152","DOI":"10.1073\/pnas.0702916104","article-title":"Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors","volume":"104","author":"Kirson","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/B978-0-12-822835-7.00002-0_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6649-9-1","article-title":"Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields)","volume":"9","author":"Kirson","year":"2009","journal-title":"BMC Med Phys"},{"issue":"8","key":"10.1016\/B978-0-12-822835-7.00002-0_bib11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1586\/ern.12.80","article-title":"NovoTTF-100A: a new treatment modality for recurrent glioblastoma","volume":"12","author":"Fonkem","year":"2012","journal-title":"Expert Rev Neurother"},{"issue":"14","key":"10.1016\/B978-0-12-822835-7.00002-0_bib12","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.ejca.2012.04.011","article-title":"NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality","volume":"48","author":"Stupp","year":"2012","journal-title":"Eur J Canc"},{"issue":"suppl 6","key":"10.1016\/B978-0-12-822835-7.00002-0_bib13","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1053\/j.seminoncol.2014.09.010","article-title":"Clinical practice experience with NovoTTF-100A system for glioblastoma: the patient registry dataset (PRiDe)","volume":"41","author":"Mrugala","year":"2014","journal-title":"Semin Oncol"},{"issue":"23","key":"10.1016\/B978-0-12-822835-7.00002-0_bib14","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial [published correction appears in JAMA","volume":"318","author":"Stupp","year":"2017","journal-title":"J\u00a0Am Med Assoc"},{"issue":"3","key":"10.1016\/B978-0-12-822835-7.00002-0_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11060-017-2601-y","article-title":"Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma","volume":"135","author":"Zhu","year":"2017","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/B978-0-12-822835-7.00002-0_bib16","series-title":"NCCN Clinical Practice Guidelines in Oncology - Central Nervous System Cancers","year":"2020"},{"issue":"2","key":"10.1016\/B978-0-12-822835-7.00002-0_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/cancers11020174","article-title":"Treatment of glioblastoma (GBM) with the addition of tumor-treating fields (TTF): a review","volume":"11","author":"Fabian","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/B978-0-12-822835-7.00002-0_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11060-018-2858-9","article-title":"Acceptance and compliance of TTFields treatment among high grade glioma patients","volume":"139","author":"Onken","year":"2018","journal-title":"J\u00a0Neuro Oncol"},{"issue":"3","key":"10.1016\/B978-0-12-822835-7.00002-0_bib19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s11060-019-03197-w","article-title":"Cost-effectiveness of tumor-treating fields added to maintenance temozolomide in patients with glioblastoma: an updated evaluation using a partitioned survival model","volume":"143","author":"Connock","year":"2019","journal-title":"J\u00a0Neuro Oncol"},{"issue":"12","key":"10.1016\/B978-0-12-822835-7.00002-0_bib20","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/S1470-2045(19)30532-7","volume":"20","author":"Ceresoli","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/B978-0-12-822835-7.00002-0_bib21","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03033992."},{"issue":"3","key":"10.1016\/B978-0-12-822835-7.00002-0_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ygyno.2018.07.018","article-title":"Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: results of the INNOVATE pilot study","volume":"150","author":"Vergote","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/B978-0-12-822835-7.00002-0_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pan.2018.10.004","article-title":"Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: results of the PANOVA phase 2 study","volume":"19","author":"Rivera","year":"2019","journal-title":"Pancreatology"},{"key":"10.1016\/B978-0-12-822835-7.00002-0_bib24","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03995667."},{"key":"10.1016\/B978-0-12-822835-7.00002-0_bib25","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03488472."},{"key":"10.1016\/B978-0-12-822835-7.00002-0_bib26","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02831959."},{"key":"10.1016\/B978-0-12-822835-7.00002-0_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuroimage.2012.12.034","article-title":"The electric field in the cortex during transcranial current stimulation","volume":"70","author":"Miranda","year":"2013","journal-title":"Neuroimage"},{"issue":"15","key":"10.1016\/B978-0-12-822835-7.00002-0_bib28","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1088\/0031-9155\/59\/15\/4137","article-title":"Predicting the electric field distribution in the brain for the treatment of glioblastoma","volume":"59","author":"Miranda","year":"2014","journal-title":"Phys Med Biol"},{"key":"10.1016\/B978-0-12-822835-7.00002-0_bib29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1477-7819-12-162","article-title":"The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF-100A system","volume":"12","author":"Turner","year":"2014","journal-title":"World J Surg Oncol"},{"issue":"10","key":"10.1016\/B978-0-12-822835-7.00002-0_bib30","doi-asserted-by":"crossref","first-page":"e0164051","DOI":"10.1371\/journal.pone.0164051","article-title":"Enhancing predicted efficacy of tumor treating fields therapy of glioblastoma using targeted surgical craniectomy: a computer modeling study","volume":"11","author":"Korshoej","year":"2016","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/B978-0-12-822835-7.00002-0_bib31","doi-asserted-by":"crossref","first-page":"04NT03","DOI":"10.1088\/1361-6560\/aafe54","article-title":"Optimization of tumor treating fields using singular value decomposition and minimization of field anisotropy","volume":"64","author":"Korshoej","year":"2019","journal-title":"Phys Med Biol"},{"issue":"1","key":"10.1016\/B978-0-12-822835-7.00002-0_bib32","first-page":"vdaa121","article-title":"OptimalTTF-1: enhancing tumor treating fields therapy with skull remodeling surgery. A clinical phase I trial in adult recurrent glioblastoma","volume":"2","author":"Korshoej","year":"2020","journal-title":"Neurooncol Adv"},{"issue":"7","key":"10.1016\/B978-0-12-822835-7.00002-0_bib33","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","article-title":"Response criteria for phase II studies of supratentorial malignant glioma","volume":"8","author":"Macdonald","year":"1990","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/B978-0-12-822835-7.00002-0_bib34","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/B978-0-12-822835-7.00002-0_bib35","first-page":"690585","article-title":"Early pseudoprogression following chemoradiotherapy in glioblastoma patients: the value of RANO evaluation","volume":"2013","author":"Linhares","year":"2013","journal-title":"J\u00a0Oncol"},{"issue":"11","key":"10.1016\/B978-0-12-822835-7.00002-0_bib36","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3174\/ajnr.A2397","article-title":"Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma","volume":"32","author":"Hygino da Cruz","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"10.1016\/B978-0-12-822835-7.00002-0_bib37","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/B978-0-12-822835-7.00002-0_bib38","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3109\/02841869009096385","article-title":"Reversible oedema and necrosis after irradiation of the brain. Diagnostic procedures and clinical manifestations","volume":"29","author":"Watne","year":"1990","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/B978-0-12-822835-7.00002-0_bib39","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1148\/radiology.144.4.6287519","article-title":"Transient early computed tomographic changes mimicking tumor progression after brain tumor irradiation","volume":"144","author":"Graeb","year":"1982","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/B978-0-12-822835-7.00002-0_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/01.WNL.0000133398.11870.9A","article-title":"Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression","volume":"63","author":"de Wit","year":"2004","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/B978-0-12-822835-7.00002-0_bib41","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1158\/1078-0432.CCR-09-1624","article-title":"Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria","volume":"15","author":"Wolchok","year":"2009","journal-title":"Clin Canc Res"},{"issue":"15","key":"10.1016\/B978-0-12-822835-7.00002-0_bib42","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S1470-2045(15)00088-1","article-title":"Immunotherapy response assessment in neuro-oncology: a report of the RANO working group","volume":"16","author":"Okada","year":"2015","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/B978-0-12-822835-7.00002-0_bib43","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","article-title":"iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics [published correction appears in Lancet Oncol. 2019 May;20(5):e242]","volume":"18","author":"Seymour","year":"2017","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/B978-0-12-822835-7.00002-0_bib44","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/neuonc\/not085","article-title":"Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery","volume":"15","author":"Boothe","year":"2013","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/B978-0-12-822835-7.00002-0_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2006.10.010","article-title":"Effect of bevacizumab on radiation necrosis of the brain","volume":"67","author":"Gonzalez","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"34","key":"10.1016\/B978-0-12-822835-7.00002-0_bib46","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1200\/JCO.2008.19.1866","article-title":"Bevacizumab reverses cerebral radiation necrosis","volume":"26","author":"Wong","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/B978-0-12-822835-7.00002-0_bib47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clinimag.2012.02.016","article-title":"MRI perfusion in determining pseudoprogression in patients with glioblastoma","volume":"37","author":"Young","year":"2013","journal-title":"Clin Imag"},{"issue":"2","key":"10.1016\/B978-0-12-822835-7.00002-0_bib48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3174\/ajnr.A1362","article-title":"Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging","volume":"30","author":"Barajas","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1016\/B978-0-12-822835-7.00002-0_bib49","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1148\/radiol.10091440","article-title":"Changes in relative cerebral blood volume 1\u00a0month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma","volume":"256","author":"Mangla","year":"2010","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/B978-0-12-822835-7.00002-0_bib50","first-page":"1316","article-title":"Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy","volume":"22","author":"Schlemmer","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"issue":"suppl 1","key":"10.1016\/B978-0-12-822835-7.00002-0_bib51","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1148\/rg.26si065513","article-title":"Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults","volume":"26","author":"Al-Okaili","year":"2006","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/B978-0-12-822835-7.00002-0_bib52","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.clinimag.2012.08.008","article-title":"Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patients","volume":"37","author":"Hatzoglou","year":"2013","journal-title":"Clin Imag"},{"issue":"suppl 1","key":"10.1016\/B978-0-12-822835-7.00002-0_bib53","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000099813","article-title":"Positron emission tomography using 18F-fluorodeoxyglucose in patients with stereotactically irradiated brain metastases","volume":"66","author":"Ericson","year":"1996","journal-title":"Stereotact Funct Neurosurg"},{"issue":"3","key":"10.1016\/B978-0-12-822835-7.00002-0_bib54","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ijc.1016","article-title":"The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery","volume":"96","author":"Chao","year":"2001","journal-title":"Int J Canc"},{"issue":"4","key":"10.1016\/B978-0-12-822835-7.00002-0_bib55","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/WCO.0000000000000574","article-title":"Update on amino acid PET of brain tumours","volume":"31","author":"Langen","year":"2018","journal-title":"Curr Opin Neurol"},{"issue":"9","key":"10.1016\/B978-0-12-822835-7.00002-0_bib56","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/MNM.0000000000001060","article-title":"Diagnostic value of radiolabeled amino acid PET for detection of pseudoprogression of brain tumor after treatment: a meta-analysis","volume":"40","author":"Kim","year":"2019","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1016\/B978-0-12-822835-7.00002-0_bib57","first-page":"vdaa119","article-title":"Preclinical and first-in-human-brain-cancer applications of [18F]poly (ADP-ribose) polymerase inhibitor PET\/MR","volume":"2","author":"Young","year":"2020","journal-title":"Neurooncol Adv"},{"issue":"suppl 6","key":"10.1016\/B978-0-12-822835-7.00002-0_bib58","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1053\/j.seminoncol.2014.09.009","article-title":"Response patterns of recurrent glioblastomas treated with tumor treating fields (TTFields)","volume":"41","author":"Vymazal","year":"2014","journal-title":"Semin Oncol"},{"issue":"1","key":"10.1016\/B978-0-12-822835-7.00002-0_bib59","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12032-012-0338-1","article-title":"Delayed response and survival from NovoTTF-100A in recurrent GBM","volume":"30","author":"Villano","year":"2013","journal-title":"Med Oncol"},{"issue":"4","key":"10.1016\/B978-0-12-822835-7.00002-0_bib60","doi-asserted-by":"crossref","first-page":"046011","DOI":"10.1088\/1741-2560\/8\/4\/046011","article-title":"Optimized multi-electrode stimulation increases focality and intensity at target","volume":"8","author":"Dmochowski","year":"2011","journal-title":"J\u00a0Neural Eng"},{"key":"10.1016\/B978-0-12-822835-7.00002-0_bib61","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neuroimage.2013.12.002","article-title":"Optimization of multifocal transcranial current stimulation for weighted cortical pattern targeting from realistic modeling of electric fields","volume":"89","author":"Ruffini","year":"2014","journal-title":"Neuroimage"}],"container-title":["Handbook of Neuro-Oncology Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128228357000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128228357000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T11:42:56Z","timestamp":1661514176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128228357000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780128228357"],"references-count":61,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-822835-7.00002-0","relation":{},"subject":[],"published":{"date-parts":[[2022]]}}}